Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-221755
Filing Date
2026-05-13
Accepted
2026-05-13 16:30:47
Documents
90
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q huma-20260331.htm   iXBRL 10-Q 2786522
2 EX-31.1 huma-ex31_1.htm EX-31.1 17455
3 EX-31.2 huma-ex31_2.htm EX-31.2 17480
4 EX-32.1 huma-ex32_1.htm EX-32.1 8773
5 EX-32.2 huma-ex32_2.htm EX-32.2 8775
  Complete submission text file 0001193125-26-221755.txt   14199107

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT huma-20260331.xsd EX-101.SCH 2099516
94 EXTRACTED XBRL INSTANCE DOCUMENT huma-20260331_htm.xml XML 3026069
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39532 | Film No.: 26973909
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)